Last reviewed · How we verify
Biological samplings
Biological samplings involve the collection and analysis of biological samples to understand disease mechanisms and monitor treatment response.
Biological samplings involve the collection and analysis of biological samples to understand disease mechanisms and monitor treatment response. Used for Monitoring of disease progression in cancer patients.
At a glance
| Generic name | Biological samplings |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
Biological samplings can include various types of samples such as blood, tissue, or urine, and can be used to identify biomarkers, monitor disease progression, and assess treatment efficacy.
Approved indications
- Monitoring of disease progression in cancer patients
Common side effects
- None reported
Key clinical trials
- In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized NMO (NA)
- Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin (NA)
- Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:
- Evaluation of Pesticide Exposure in the General Population
- Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn's Disease
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Biological samplings CI brief — competitive landscape report
- Biological samplings updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI